| An evidence-based review of statin use in patients with nonalcoholic fatty liver disease MA Sigler, L Congdon, KL Edwards Clinical Medicine Insights: Gastroenterology 11, 1179552218787502, 2018 | 61 | 2018 |
| Dosing considerations for obese patients receiving cancer chemotherapeutic agents RG Hall, GW Jean, M Sigler, S Shah Annals of Pharmacotherapy 47 (12), 1666-1674, 2013 | 41 | 2013 |
| Assessment of appropriate antibiotic prescribing for urinary tract infections in an internal medicine clinic. M Sigler, JE Leal, K Bliven, B Cogdill, A Thompson Southern medical journal 108 (5), 300-304, 2015 | 22 | 2015 |
| Assessment of Glycemic Control in Veterans With Chronic Obstructive Pulmonary Disease and Type 2 Diabetes Mellitus on Inhaled Corticosteroid Therapy MP Lempp, MA Sigler, AA Adesoye, A Ponnuru, CE Duval Journal of Pharmacy Practice 35 (1), 7-12, 2022 | 2 | 2022 |
| Effect of pregabalin initiation on diuretic requirements in patients with chronic heart failure A Basri, MA Sigler, KC Kelly, DH Lopez, CA Alvarez Journal of the American Pharmacists Association 64 (3), 102063, 2024 | | 2024 |
| Chronic Obstructive Pulmonary Disease, Part 5: Clinical Pearls for Comorbid COPD KM Clifford, MS Klein, LA Courtney, A Van Dyke, M Sigler, RL Basinger The Senior Care Pharmacist 38 (10), 404-415, 2023 | | 2023 |
| 872-P: Utilization of Empagliflozin in Patients with Type 2 Diabetes Mellitus and Congestive Heart Failure CA ALVAREZ, A PERKINS, MA SIGLER, HUI YANG, H CABERWAL, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| 873-P: Empagliflozin Compliance and Influencing Factors in Patients with Heart Failure and Diabetes CA ALVAREZ, A PERKINS, MA SIGLER, HUI YANG, H CABERWAL, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| MeRIT Project: Effectiveness of empagliflozin in Veterans with heart failure with reduced ejection fraction and type 2 diabetes mellitus recently hospitalized for acute … M Sigler, R Parker, A Perkins, C Alvarez 2022 ACCP Virtual Poster Symposium (May 24 and 25), 2022 | | 2022 |
| 2021 ACCP MeRIT Project: Effectiveness of empagliflozin in Veterans Affairs patients with type 2 diabetes mellitus and heart failure with reduced ejective fraction with a … M Sigler, R Parker, C Alvarez 2021 ACCP VIRTUAL Annual Meeting, 2021 | | 2021 |
| Differences in outcomes among racial groups in patients receiving angiotensin receptor blocker/neprilysin inhibitors for reduced ejection fraction heart failure SY Kong, M Lempp, M Sigler, C Alvarez, K Edwards 2020 ACCP VIRTUAL Annual Meeting (October 19-30), 2020 | | 2020 |
| Pharmacist Involvement in Care Transitions in an Academic Medical Center MA Sigler, AN Thompson J Anal Pharm Res 5 (1), 00129, 2017 | | 2017 |
| Evaluating the role of serotonin-norepinephrine reuptake inhibitors for the treatment of painful diabetic peripheral neuropathy M Sigler, MA Seminar | | 2016 |
| Evidence and clinical considerations for the use of serotonin and norepinephrine reuptake inhibitors for the treatment of painful neuropathy M Sigler, A VandenBerg, A Thompson Mental Health Clinician 5 (6), 289-295, 2015 | | 2015 |
